Quarterly report [Sections 13 or 15(d)]

Segment Reporting (Tables)

v3.26.3
Segment Reporting (Tables)
 9 Months Ended
Sep. 30, 2026
Segment Reporting [Abstract]  
Segment Reporting The following tables present information about the Company’s reportable segment:
Three Months Ended September 30, Nine Months Ended September 30,
2026 2025 2026 2025
(in thousands)
Operating revenue $ 396,344  $ 345,253  $ 1,169,115  $ 1,074,266 
Less:
Medical claims expense (322,357) (337,143) (896,794) (1,010,569)
Other medical expense(1)
(23,644) (32,646) (85,608) (82,613)
Depreciation and amortization (21,038) (21,033) (63,156) (63,168)
Other segment items(2)
6,251  (3,810) (54,664) (34,063)
Interest expense
 (5,042) (20,527) (29,670) (39,397)
Interest income 286  456  536  1,237 
Income (loss) before income taxes 30,800  (69,450) 39,759  (154,307)
Income tax (provision) benefit
 (23) (11) 9,709  (3,065)
Net income (loss)
 $ 30,777  $ (69,461) $ 49,468  $ (157,372)
September 30, 2026 December 31, 2025
(in thousands)
Segment assets $ 134,384  $ 92,458 
Other assets(3)
535,335  564,183 
Total assets $ 669,719  $ 656,641 
__________________
(1)Other medical expense includes subcapitation expense, affiliate provider compensation expense, and other non-claim costs.
(2)Other segment items include premium deficiency reserve, corporate, general and administrative expense, and miscellaneous income and expense.
(3)Other assets consists of cash, restricted cash, prepaid expenses and other current assets, other receivables, assets held for sale, and other long-term assets not allocated to the reportable segment.